Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 9 | 2014 | 99 | 1.650 |
Why?
|
| Facial Nerve Diseases | 4 | 2015 | 13 | 1.520 |
Why?
|
| Facial Nerve | 4 | 2015 | 25 | 1.470 |
Why?
|
| Cranial Nerve Neoplasms | 3 | 2015 | 13 | 1.410 |
Why?
|
| Neurilemmoma | 3 | 2015 | 26 | 1.380 |
Why?
|
| Cochlear Implants | 6 | 2014 | 110 | 1.100 |
Why?
|
| Radiosurgery | 3 | 2015 | 66 | 1.040 |
Why?
|
| Cochlea | 5 | 2014 | 169 | 1.010 |
Why?
|
| Neuroma, Acoustic | 2 | 2015 | 17 | 0.990 |
Why?
|
| Meniere Disease | 2 | 2014 | 31 | 0.910 |
Why?
|
| Temporal Bone | 3 | 2014 | 53 | 0.910 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2014 | 629 | 0.670 |
Why?
|
| Surgery, Computer-Assisted | 4 | 2014 | 52 | 0.660 |
Why?
|
| Postoperative Complications | 3 | 2014 | 1615 | 0.560 |
Why?
|
| Granular Cell Tumor | 1 | 2015 | 9 | 0.510 |
Why?
|
| Skull Base Neoplasms | 1 | 2015 | 13 | 0.510 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 7 | 0.490 |
Why?
|
| Suture Anchors | 1 | 2014 | 9 | 0.490 |
Why?
|
| Meningeal Neoplasms | 1 | 2015 | 42 | 0.490 |
Why?
|
| Hemangioma | 1 | 2015 | 51 | 0.490 |
Why?
|
| Stapes Surgery | 1 | 2014 | 3 | 0.480 |
Why?
|
| Stapes | 1 | 2014 | 7 | 0.480 |
Why?
|
| Hearing Aids | 1 | 2014 | 34 | 0.480 |
Why?
|
| Meningioma | 1 | 2015 | 54 | 0.480 |
Why?
|
| Ear, Inner | 1 | 2014 | 47 | 0.470 |
Why?
|
| Skull Neoplasms | 1 | 2014 | 23 | 0.470 |
Why?
|
| Electric Impedance | 1 | 2014 | 131 | 0.470 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 98 | 0.460 |
Why?
|
| Dexamethasone | 1 | 2014 | 150 | 0.460 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 83 | 0.460 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 446 | 0.450 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 234 | 0.420 |
Why?
|
| Ear, Middle | 1 | 2012 | 32 | 0.410 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2011 | 9 | 0.390 |
Why?
|
| Hearing Loss | 1 | 2014 | 154 | 0.380 |
Why?
|
| Speech Perception | 1 | 2014 | 261 | 0.370 |
Why?
|
| Electroconvulsive Therapy | 1 | 2014 | 402 | 0.350 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2008 | 94 | 0.310 |
Why?
|
| Laryngeal Neoplasms | 1 | 2008 | 47 | 0.310 |
Why?
|
| Humans | 24 | 2015 | 68618 | 0.280 |
Why?
|
| Treatment Outcome | 7 | 2015 | 7029 | 0.280 |
Why?
|
| Male | 15 | 2015 | 37321 | 0.260 |
Why?
|
| Body Mass Index | 1 | 2008 | 867 | 0.240 |
Why?
|
| Middle Aged | 10 | 2014 | 21147 | 0.240 |
Why?
|
| Geniculate Ganglion | 2 | 2015 | 3 | 0.230 |
Why?
|
| Tympanic Membrane | 2 | 2014 | 25 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2014 | 2324 | 0.220 |
Why?
|
| Female | 12 | 2015 | 38074 | 0.220 |
Why?
|
| Aged | 7 | 2014 | 14862 | 0.220 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2013 | 85 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2015 | 2223 | 0.200 |
Why?
|
| Retrospective Studies | 5 | 2014 | 7277 | 0.200 |
Why?
|
| Otologic Surgical Procedures | 2 | 2012 | 23 | 0.200 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2012 | 13 | 0.200 |
Why?
|
| Tympanoplasty | 2 | 2011 | 13 | 0.200 |
Why?
|
| Mastoid | 2 | 2011 | 20 | 0.190 |
Why?
|
| Adult | 8 | 2014 | 21403 | 0.190 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 3259 | 0.170 |
Why?
|
| Child | 5 | 2014 | 6405 | 0.170 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 800 | 0.160 |
Why?
|
| Infant | 3 | 2012 | 2891 | 0.140 |
Why?
|
| Pattern Recognition, Automated | 2 | 2014 | 70 | 0.140 |
Why?
|
| Child, Preschool | 3 | 2012 | 3187 | 0.140 |
Why?
|
| Glomus Jugulare Tumor | 1 | 2015 | 4 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 2 | 2012 | 561 | 0.130 |
Why?
|
| History, 19th Century | 1 | 2015 | 95 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2015 | 127 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 4848 | 0.120 |
Why?
|
| Cadaver | 1 | 2014 | 136 | 0.120 |
Why?
|
| Electrodes, Implanted | 1 | 2014 | 98 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2015 | 248 | 0.120 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2013 | 3 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2014 | 240 | 0.110 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 29 | 0.110 |
Why?
|
| Facial Paralysis | 1 | 2013 | 25 | 0.110 |
Why?
|
| Fiducial Markers | 1 | 2013 | 10 | 0.110 |
Why?
|
| Radiography | 1 | 2014 | 572 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 369 | 0.110 |
Why?
|
| Round Window, Ear | 1 | 2012 | 8 | 0.100 |
Why?
|
| Acellular Dermis | 1 | 2012 | 2 | 0.100 |
Why?
|
| Ear Canal | 1 | 2012 | 24 | 0.100 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 159 | 0.100 |
Why?
|
| Papillomaviridae | 1 | 2012 | 104 | 0.100 |
Why?
|
| Parotid Gland | 1 | 2012 | 33 | 0.100 |
Why?
|
| Chorda Tympani Nerve | 1 | 2011 | 1 | 0.100 |
Why?
|
| Skin Transplantation | 1 | 2012 | 45 | 0.100 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2011 | 2 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 689 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 242 | 0.100 |
Why?
|
| Scala Tympani | 1 | 2011 | 1 | 0.100 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 373 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2011 | 143 | 0.090 |
Why?
|
| Algorithms | 2 | 2014 | 1196 | 0.090 |
Why?
|
| Adolescent | 3 | 2012 | 8912 | 0.090 |
Why?
|
| Auditory Threshold | 1 | 2011 | 206 | 0.090 |
Why?
|
| Reoperation | 1 | 2011 | 467 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2012 | 880 | 0.080 |
Why?
|
| Risk Factors | 3 | 2014 | 5731 | 0.080 |
Why?
|
| Collagen | 1 | 2012 | 636 | 0.080 |
Why?
|
| Alphapapillomavirus | 1 | 2008 | 17 | 0.080 |
Why?
|
| Recurrence | 1 | 2011 | 948 | 0.080 |
Why?
|
| Radiotherapy, Conformal | 1 | 2008 | 24 | 0.080 |
Why?
|
| Carboplatin | 1 | 2008 | 59 | 0.080 |
Why?
|
| Endoscopy | 1 | 2011 | 464 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2008 | 219 | 0.070 |
Why?
|
| Cisplatin | 1 | 2008 | 192 | 0.070 |
Why?
|
| Gastrostomy | 1 | 2008 | 110 | 0.070 |
Why?
|
| Enteral Nutrition | 1 | 2008 | 157 | 0.070 |
Why?
|
| Equipment Design | 3 | 2012 | 500 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 792 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2008 | 194 | 0.070 |
Why?
|
| Aging | 1 | 2012 | 911 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 951 | 0.070 |
Why?
|
| Survival Rate | 1 | 2008 | 1056 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 468 | 0.060 |
Why?
|
| Prognosis | 1 | 2008 | 2093 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 31 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2003 | 74 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1174 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 2077 | 0.040 |
Why?
|
| KRIT1 Protein | 1 | 2013 | 1 | 0.030 |
Why?
|
| Ankyrin Repeat | 1 | 2013 | 1 | 0.030 |
Why?
|
| Pedigree | 1 | 2013 | 159 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 114 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 201 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2013 | 235 | 0.030 |
Why?
|
| Microdissection | 1 | 2012 | 15 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 208 | 0.030 |
Why?
|
| Acute Disease | 1 | 2013 | 658 | 0.020 |
Why?
|
| Endoscopes | 1 | 2011 | 36 | 0.020 |
Why?
|
| Otitis Media, Suppurative | 1 | 2011 | 4 | 0.020 |
Why?
|
| Automation | 1 | 2011 | 45 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2011 | 51 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 411 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 710 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2012 | 89 | 0.020 |
Why?
|
| Hearing | 1 | 2012 | 133 | 0.020 |
Why?
|
| Audiometry | 1 | 2011 | 50 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 442 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1140 | 0.020 |
Why?
|
| Wound Healing | 1 | 2012 | 260 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 333 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 955 | 0.020 |
Why?
|
| Graft Survival | 1 | 2012 | 465 | 0.020 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Tonsillar Neoplasms | 1 | 2008 | 7 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1465 | 0.020 |
Why?
|
| Tongue Neoplasms | 1 | 2008 | 29 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2008 | 93 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2012 | 458 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2008 | 114 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2008 | 110 | 0.020 |
Why?
|
| Papillomavirus Vaccines | 1 | 2008 | 93 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 2083 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 1330 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 2007 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 848 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2550 | 0.010 |
Why?
|
| Rats | 1 | 2012 | 5300 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 67 | 0.010 |
Why?
|
| Lysine | 1 | 2003 | 96 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 358 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 234 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2358 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 805 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1083 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 284 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1447 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 306 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 1452 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 20881 | 0.010 |
Why?
|